OOIR: Observatory of International Research

Papers

(The median citation count of JAMA Neurology is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)

Article	Citations
Diplopia and Ptosis in an Older Woman	480
Somebody to Love	475
Optimizing the Time Course of Risks and Benefits of Acute Dual Antiplatelet Therapy for Stroke Prevention	462
Early Posttraumatic Seizures—Putting Things in Perspective	368
A Call to Action to Address Sex Differences in Alzheimer Disease Clinical Trials	361
Equipping AI for Unbiased and Inclusive Neurology	228
Itching Frequency and Neuroanatomic Correlates in Frontotemporal Lobar Degeneration	227
Error in Author Name	222
Automated Imaging Differentiation for Parkinsonism	218
Origin of Transthyretin in Cerebral Amyloid Angiopathy	212
Ghrelin for Neuroprotection in Post–Cardiac Arrest Coma	209
Optimal Delay Time to Initiate Anticoagulation After Ischemic Stroke in Atrial Fibrillation	204
Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance	204
Comparison Between Dimethyl Fumarate, Fingolimod, and Ocrelizumab After Natalizumab Cessation	204
Association of Disease-Modifying Treatment and Anti-CD20 Infusion Timing With Humoral Response to 2 SARS-CoV-2 Vaccines in Patients With Multiple Sclerosis	204
Risk of Dementia in Individuals With Emergency Department Visits or Hospitalizations Due to Cannabis	199
Substantia Nigra Pathology, Contact Sports Play, and Parkinsonism in Chronic Traumatic Encephalopathy	189
Association Between Increased Seizures During Rewarming After Hypothermia for Neonatal Hypoxic Ischemic Encephalopathy and Abnormal Neurodevelopmental Outcomes at 2-Year Follow-up	187
Rizatriptan vs Placebo for Attacks of Vestibular Migraine	173
Alternate Hemibody Hyperkinetic and Hypokinetic Movement Disorders Due to Strategic Lesions in Cerebral Toxoplasmosis	172
Magnetic Resonance Imaging Features of Tropical Candidal Meningoencephalitis	171
Reinterpreting Clinical Trials in Children With Multiple Sclerosis Using a Bayesian Approach	154
JAMA Neurology	152
JAMA Neurology	151
Is It Really Itching?	150

The Neurologist’s Imperative in Brain Death	146
Anticoagulation and Antiplatelet Therapy in Patients With Atrial Fibrillation and Atherosclerosis	144
Teleneurorehabilitation and Motor and Nonmotor Symptoms and Quality of Life in Parkinson Disease	139
Thrombolysis With Tenecteplase for Minor Disabling Stroke	137
External Carotid Artery Angioplasty Based on Ultrahigh-Resolution Photon-Counting CTA	136
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis	134
Isosorbide Mononitrate and Cilostazol Treatment in Patients With Symptomatic Cerebral Small Vessel Disease	130
Time to Change the Current Clinical Classification of Multiple Sclerosis?	130
Functional Outcomes in Conservatively vs Surgically Treated Cerebellar Infarcts	129
Time From Hospital Arrival Until Endovascular Thrombectomy and Patient-Reported Outcomes in Acute Ischemic Stroke	124
Alzheimer Disease as a Clinical-Biological Construct—An International Working Group Recommendation	119
Effect of Neprilysin Inhibition on Alzheimer Disease Plasma Biomarkers	116
N-Acetylcysteine for Hereditary Cystatin C Amyloid Angiopathy	115
Do Neurologists Need a Goldwater Rule?	111
Error in Abstract	111
Disentangling Workflow Paradigms and Treatment Decision-making in Acute Ischemic Stroke	105
Error in Figure	101
Histologic Anatomy of Neurocysticercosis	101
Error in Additional Contributions	100
Functional Seizures—A Critical Comorbidity Overlooked in Epilepsy Research—Reply	97
Error in Figure	97
Spontaneous AICA Dissection Presenting With Isolated Audiovestibular Loss	97
Posttreatment Amyloid Levels and Clinical Outcomes Following Donanemab for Early Symptomatic Alzheimer Disease	96
Association of Cardiovascular Events With Spouse’s Subsequent Dementia	95
Sleep Recording for the Diagnosis and Treatment of Paraplegia	95
Is It Really Itching?—Reply	95
Spinal Cerebrospinal Fluid Leak Mimicking a Cerebellopontine Angle Tumor	94
JAMA Neurology	93
β-Amyloid Positron Emission Tomography Use Across Medicare Administrative Contractor Regions	93
Seizure Frequency Trends Over Time in Treatment-Resistant Focal Epilepsy	91
Visual Neglect After an Isolated Lesion of the Superior Colliculus	91
Intra-Arterial Tenecteplase After Successful Reperfusion in Large Vessel Occlusion Stroke	89
Retinal Hemorrhage Associated with Human Granulocytic Anaplasmosis	89
Prourokinase vs Standard Care for Patients With Mild Ischemic Stroke	88
Tackling the Unmet Therapeutic Needs in Nonsurgical Treatments for Epilepsy	87
Contribution of Somatic Ras/Raf/Mitogen-Activated Protein Kinase Variants in the Hippocampus in Drug-Resistant Mesial Temporal Lobe Epilepsy	86
Risk Factors Associated With Late-Onset Epilepsy in Dementia and Mild Cognitive Impairment	84
Endovascular Stroke Thrombectomy for Patients With Large Ischemic Core	84
Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke With Large-Vessel Occlusion	84
Role of the X Chromosome in Alzheimer Disease Genetics	82
Current and Future Roles of Chimeric Antigen Receptor T-Cell Therapy in Neurology	82
Interhemispheric Bullet Migration—A Surgical Dilemma	82
GLP-1RA and SGLT2i Medications for Type 2 Diabetes and Alzheimer Disease and Related Dementias	82
Prevalence Estimates of Amyloid Abnormality Across the Alzheimer Disease Clinical Spectrum	81
Neuronally Derived Extracellular Vesicle α-Synuclein as a Serum Biomarker for Individuals at Risk of Developing Parkinson Disease	78
JAMA Neurology	78
Error in Text	76
JAMA Neurology	76
Acute Myelopathy in a Man With Cutaneous Papules	75
Perceived CTE and Suicidality—Is Perception Reality?	75

Peripheral-Type Facial Paralysis and Unilateral Hemisphere Hemorrhage	74
Error in Figures	74
Behavioral Compared With Drug Therapy for Overactive Bladder Symptoms in Parkinson Disease	74
Error in Key for Figure 3	74
A Rare Neurological Presentation of Kikuchi-Fujimoto Disease	73
Ongoing Challenges in the Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease	73
A 62-Year-Old Man With Progressive Limb Weakness, Involuntary Movements, and HyperCKemia	72
AI Devices in Neurology—Moving From Diagnosis to Prognosis	70
Visualization of Parkinsonian Tongue Tremor on Ultrasonography	70
The New Era of Automated Electroencephalogram Interpretation	69
Bibrachial Amyotrophy Due to Spontaneous Spinal Cerebrospinal Fluid Leak	69
Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura	67
Functional Impairment in Individuals With Prodromal or Unrecognized Parkinson Disease	66
Magnetic Resonance Imaging Features of GABA-A Receptor Antibody-Mediated Encephalitis	66
Symptomatic Intracranial Hemorrhage With Tenecteplase vs Alteplase in Patients With Acute Ischemic Stroke	65
Expanding Clinical Spectrum of Anti-GQ1b Antibody Syndrome	65
“The Triage of Privilege” Factual Concerns	64
Comparison of Perinatal Outcomes for Women With and Without Epilepsy	64
IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease	64
Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis	63
Minimally Invasive Surgery vs Medical Management Alone for Intracerebral Hemorrhage	63
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients	62
Detection of Brain Tau Pathology in Down Syndrome Using Plasma Biomarkers	62
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated Syndrome	62
Emerging Cerebrospinal Fluid Biomarkers of Disease Activity and Progression in Multiple Sclerosis	62
The Semont-Plus Maneuver or the Epley Maneuver in Posterior Canal Benign Paroxysmal Positional Vertigo	61
The Choreoathetotic Movement of Paroxysmal Nonkinesigenic Dyskinesia	60
Repairing Our View of Dementia	60
Concerns Remain Regarding Ambient NO₂ Exposure and the Risk of Parkinson Disease—Reply	60
JAMA Neurology Peer Reviewers in 2021	60
Benefits and Risks of Periconceptional Folic Acid Supplementation—Reply	59
Error in Title	59
Livedo Reticularis—A Presenting Sign of Neuromyelitis Optica Spectrum Disorder	59
IWG and AA Criteria—Where the Differences Matter—Reply	58
Cerebral Amyloid Angiopathy—How to Translate Updated Diagnostic Criteria for This Multifaceted Disorder to Clinical Practice?	58
Benefits and Risks of Periconceptional Folic Acid Supplementation	57
Disease-Modifying Treatments and Time to Loss of Ambulatory Function in Patients With Primary Progressive Multiple Sclerosis	57
Possible Explanations for Hearing Loss in Parkinson Disease	57
Adverse Childhood Experiences, Toxic Stress, and Trauma-Informed Neurology	56
Life Expectancy for Patients With Sporadic Creutzfeldt-Jakob Disease	55
Reimagining the Treatment of Distal and Medium Vessel Occlusion Strokes	55
Choosing the Best Antiseizure Medication—Can Artificial Intelligence Help?	55
Autism and Parkinsonism—Terminology and Confounding	52
Novel Meningoencephalomyelitis Associated With Vimentin IgG Autoantibodies	52
Coma Prognostication After Acute Brain Injury	51
Association Between Acute Myocardial Infarction and Cognition	50
SARS-CoV-2 Vaccination and Neuroimmunological Disease	49
Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography	48
Association of Intensive vs Standard Blood Pressure Control With Cerebral Blood Flow	48
Burden of Central Nervous System Cancer in the United States, 1990-2021	48
Expanding the Prion Paradigm to Include Alzheimer and Parkinson Diseases	48
Addition of Nonauthor Collaborators and a Supplement	47
Cognitive Behavioral Therapy for Veterans With Comorbid Posttraumatic Headache and Posttraumatic Stress Disorder Symptoms	47
Alzheimer Disease Blood Biomarkers in Patients With Out-of-Hospital Cardiac Arrest	47
Monogenic Stroke—Can We Overcome Nature With Nurture?	46
The Perils and Pitfalls of Global Engagement	46
JAMA Neurology	46
Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis—Variations in Real-World Experience—Reply	46
A Woman With Eosinophilic Brainstem Meningoencephalitis	46
Views From Both Sides of the White Coat	45
Error in Author Affiliation	45
How Is the X Chromosome Involved in Alzheimer Disease?	44
Gantenerumab in Dominantly Inherited Alzheimer Disease—Reply	44
Chronic Immune Peripheral Nerve Myelinopathies—A Plea for Precision	44
Errors in Figure 2 and the Short Title	44
Modern Neurology Training Is Failing Outpatients	42
GLP-1 RAs for Idiopathic Intracranial Hypertension—Time for a Trial	42
Efficacy and Safety of Ravulizumab, a Complement C5 Inhibitor, in Adults With Amyotrophic Lateral Sclerosis	42
Structural Inequities for Historically Underserved Communities in the Adoption of Stroke Certification in the United States	42
Visual Impairment as a Modifiable Risk Factor in Dementia Prevention and Management	42
Incidence and Risk Factors of Epilepsy Among Older Adults in the US Medicare Population	42
Citius, Fortius, Altius—Understanding Which Components Drive Exercise Benefits in Parkinson Disease	42
Transcarotid Artery Revascularization for Stroke Prevention—Multiple Elephants in the Room	42
Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage	41
Association Between Antiseizure Drug Monotherapy and Mortality for Patients With Poststroke Epilepsy	41
Intravenous Thrombolysis in Patients With Ischemic Stroke and Recent Ingestion of Direct Oral Anticoagulants	41
Medical Forecasting—A Skill Set Worthy of Attention	41
Evaluating the Safety and Efficacy of Crenezumab vs Placebo in Adults With Early Alzheimer Disease	40
One-Year Trajectory of Cognitive Changes in Older Survivors of COVID-19 in Wuhan, China	40
Discontinuation of First-Line Disease-Modifying Therapy in Patients With Stable Multiple Sclerosis	40

Targeting B Cells and Microglia in Multiple Sclerosis With Bruton Tyrosine Kinase Inhibitors	40
Mitigating the Associations of Kidney Dysfunction With Blood Biomarkers of Alzheimer Disease by Using Phosphorylated Tau to Total Tau Ratios	39
The End Justifies the Means—A Call for Nuance in the Increasing Nationwide Adoption of Stereoelectroencephalography Over Subdural Electrode Monitoring in the Surgical Evaluation of Intractable Epileps	39
TDP-43 Accumulation Within Intramuscular Nerve Bundles of Patients With Amyotrophic Lateral Sclerosis	39
Association of Aortic Stiffness and Pressure Pulsatility With Global Amyloid-β and Regional Tau Burden Among Framingham Heart Study Participants Without Dementia	39
Exome Sequencing and the Identification of New Genes and Shared Mechanisms in Polymicrogyria	39
JAMA Neurology	38
Bilateral Complete Ophthalmoplegia in a 50-Year-Old Man	38
Error in Title	38
Error in Figures 2 and 3	37
JAMA Neurology	37
A 51-Year-Old Woman With Abnormal Corpus Callosum Signal	37
CT Perfusion Imaging After Selection for Late-Window Endovascular Stroke Treatment	37
Acute Ischemic Stroke Care Quality Improvement	37
Error in Open Access Status	36
Multimodal Neuroimaging of Intimal Flap in a Basilar Artery Dissection	36
Targeting Sleep and Circadian Function in the Prevention of Alzheimer Disease	35
Discussion on the Application of Rapid Immunoblot Assay for AQP4-IgG Detection	35
Genome Sequencing After Exome Sequencing in Pediatric Epilepsy	34
2024 Diagnostic Criteria for Multiple Sclerosis—A Unified Approach	34
Venture Capital Investment in Neurology Companies	34
Transient Focal Neurological Events in Cerebral Amyloid Angiopathy and the Long-term Risk of Intracerebral Hemorrhage and Death	34
Endovascular Thrombectomy Treatment Effect in Direct vs Transferred Patients With Large Ischemic Strokes	34
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis	34
Risks of Expanded Medicare Coverage of Carotid Artery Stenting	33
Cerebrospinal Fluid Biomarkers for Alzheimer Disease Among Patients With Dementia	33
White Matter Tract Density Index Prediction Model of Overall Survival in Glioblastoma	33
Batoclimab vs Placebo for Generalized Myasthenia Gravis	33
An Acetylcholine M₁ Receptor–Positive Allosteric Modulator (TAK-071) in Parkinson Disease With Cognitive Impairment	33
Recurrent Ischemic Stroke in Patients With Atrial Fibrillation While Receiving Oral Anticoagulants	33
Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease	33
Risk of Stroke, Death, and Myocardial Infarction Following Transcarotid Artery Revascularization vs Carotid Endarterectomy in Patients With Standard Surgical Risk	32
Immediate- or Delayed-Intensive Statin in Acute Cerebral Ischemia	32
Advocating for Demonstration of Disease Modification—Have We Been Approaching Clinical Trials in Early Alzheimer Disease Incorrectly?	32
ApoE4 and Connectivity-Mediated Spreading of Tau Pathology at Lower Amyloid Levels	31
Directly Isolated Allogeneic Virus–Specific T Cells in Progressive Multifocal Leukoencephalopathy	31
Neurologic Complications of Smallpox and Monkeypox	30
Efficacy and Safety of Erenumab for Nonopioid Medication Overuse Headache in Chronic Migraine	30
Risk Factors for Young-Onset Dementia in the UK Biobank	30
Multisite Skin Biopsies vs Cerebrospinal Fluid for Prion Seeding Activity in the Diagnosis of Prion Diseases	30
Error in Methods	30
Development and Validation of a Deep Learning Model for Predicting Treatment Response in Patients With Newly Diagnosed Epilepsy	30
Physical Frailty, Genetic Predisposition, and Incident Parkinson Disease	30
E-Cigarettes and Stroke Risk—Present Uncertainties and Future Directions	30
Entering Medicine as a Physician and a Patient	29
A Funeral for a Neurologist	29
Association Between Use of Angiotensin Receptor Blockers and Incidence of Epilepsy in Patients With Hypertension—Reply	29
Inducers and Cardiovascular Risk—Potential Role for Lowered Drug Exposure	29
Paused—A Residency Interrupted	29
Light Reading—The Gravity of Postoperative Care	29
Neuro-Advocacy—Professionalism in Action	28
Intramedullary Hemorrhage Causing Quadriplegia in the Setting of a Type B Aortic Dissection	28
Rethinking the Menopause Transition and Multiple Sclerosis Progression	28
A New Dystonia Phenotype in Wilson Disease	28
Remembering the Physician’s Humanity—Physicians Are Humans Too	28
Butter Yellow—A Soft Hue With Neurological Implications	28
Embedded Human Closed-Loop Deep Brain Stimulation for Tourette Syndrome	27
Postmortem Assessment of Olfactory Tissue Degeneration and Microvasculopathy in Patients With COVID-19	27
Association of Tourette Syndrome and Chronic Tic Disorder With Violent Assault and Criminal Convictions	27
Gene Therapy vs Cochlear Implantation in Restoring Hearing Function and Speech Perception for Individuals With Congenital Deafness	27
What Should the Goals Be for Diverse Recruitment in Alzheimer Clinical Trials?	27
Effect of Irrigation Fluid Temperature on Recurrence in the Evacuation of Chronic Subdural Hematoma	27
Quality Improvement Intervention for Reducing Acute Treatment Times in Ischemic Stroke	27
Pattern of Recurrent Nontraumatic Intracerebral Hemorrhage—Reply	27
Distinguishing Frontotemporal Lobar Degeneration Tau From TDP-43 Using Plasma Biomarkers	26
JAMA Neurology Editorial Fellowship	26
Lecanemab Treatment in a Specialty Memory Clinic	26
Safety and Efficacy of Staged, Bilateral Focused Ultrasound Thalamotomy in Essential Tremor	26
Clinical Utility of Tau Positron Emission Tomography in the Diagnostic Workup of Patients With Cognitive Symptoms	26
Kelch-Like Protein 11 Antibody-Associated Paraneoplastic Encephalitis	26
Error in Title	25
Bilateral Calcification of the Meckel Cave Causing Hemicrania Continua	25
Error in Figure 2B	25
Commentary on Long-term Effectiveness of Adjuvant Treatment in Parkinson Disease—Reply	25
Trends in AVM-Associated Intracranial Hemorrhage in the United States, 2000-2019	24
Anticoagulation in ESUS—Back From the Dead?	24
Error in Figures	24
Iatrogenic Cerebrospinal Fluid–Venous Fistula	24
Error in Figure 1	24
Cholinesterase Inhibitors for Treatment of Psychotic Symptoms in Alzheimer Disease and Parkinson Disease	23
Effect of Bypassing the Closest Stroke Center in Patients with Intracerebral Hemorrhage	23
Gadolinium-Enhanced Aneurysm Wall Imaging and Risk of Intracranial Aneurysm Growth or Rupture	23
How SAFE Is Real-world Use of Spinal Cord Stimulation Therapy for Chronic Pain?	23
Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database	23
Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events	23
Central Retinal Artery Occlusion With Cilioretinal Artery Sparing After Semaglutide Injection	23
Combined Physiotherapy and Cognitive Behavioral Therapy for Functional Movement Disorders	23
Risk of Inflammatory Central Nervous System Diseases After Tumor Necrosis Factor–Inhibitor Treatment for Autoimmune Diseases	23
Errors in Results in Abstract and Text and in Table 1	22
Error in Title	22
Risk Factors and Prognosis of Early Posttraumatic Seizures in Moderate to Severe Traumatic Brain Injury	22
JAMA Neurology—The Year in Review, 2023	22
Higher Educational Attainment and Accelerated Tau Accumulation in Alzheimer Disease	22
JAMA Neurology	22
Research Criteria for the Behavioral Variant of Alzheimer Disease	22